LEE011

Pharma

Novartis rolls out flex pricing scheme for Ibrance rival Kisqali

Plenty of companies have talked about—and even dabbled in—newfangled pricing schemes. But Novartis is about to seriously raise the bar with new cancer-fighter Kisqali.

Carly Helfand Mar 13, 2017 6:52pm

The top 10 drug launches of 2017

Jan 30, 2017 12:00pm